Diuril (chlorothiazide) NDC 65649-311

NDC codes

FDA NDC Directory

Product NDC (as listed)65649-311Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65649-0311Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65649-311-12	65649031112	1 BOTTLE in 1 CARTON (65649-311-12) / 237 mL in 1 BOTTLEMarketed from Feb 15, 1962

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Diuril
Generic name (nonproprietary): chlorothiazide
Active ingredients: Chlorothiazide — 250 mg/5mL
Dosage form: Suspension
Route: Oral
Labeler: Salix Pharmaceuticals, Inc
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 011870
Marketing start: Feb 15, 1962
Marketing end: Jan 31, 2028
Other FDA classes: Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 65649-311_e311f727-9882-4c42-bd5b-e8e38ee54466SPL ID e311f727-9882-4c42-bd5b-e8e38ee54466SPL set ID bd936e35-1af8-42da-bcc0-f22489d68574RxCUI 213439, 309198UNII 77W477J15H
Pharmacologic class: Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465649031112 followed by a unit qualifier and the quantity

Package 65649-0311-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 1, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE DIURIL is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. DIURIL has also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. DIURIL is indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. Use in Pregnancy - Routine use of diuretics during normal pregnancy is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)